Short, plain-language guides on GLP-1 therapy and metabolic health, written and reviewed by ZIVOLABS doctors. No clickbait. No miracle promises.
The numbers, the drivers, and why prevention has limits — making medical treatment increasingly relevant.
Pharmacists are gatekeepers, not vending machines. There's a legal reason behind the friction.
12% on the drug. 18% on some services. Here's the full breakdown so you know what's on your invoice.
The honest answer depends on the diagnosis on your claim. Here's the playbook.
Every legitimate GLP-1 pen in India passes through CDSCO. Here's what that actually means for what you receive.
Same medication, different price by city. Why and what it means for budgeting.
Every few months you hear that Ozempic is out of stock. Here's why the supply is so tight — and what alternatives are available.
What the Drugs Controller General of India has actually approved — and for which conditions.
The legal framework that makes your remote doctor consult valid. The short version, and what it requires from us.
Ozempic. Rybelsus. Wegovy. Mounjaro. Saxenda. Trulicity. What each is and which conditions they're approved for.
